Universal penny stocks focus is on Hot Penny Stocks that trade on OTCBB and OTC markets, which are mostly referred to as “penny stocks”. These Penny Stocks could offer the greatest potential return on your short or long term investment. Sign up for our free newsletter before you miss the next alert.
Dendreon Corporation (NASDAQ:DNDN) recently declared that management will host a conference call on Monday, February 25, 2012, at 9:00 a.m. ET for the preview of fourth quarter and full year 2012 financial results. Dendreon Corporation also declared that management will also present at Leerink Swann Global Healthcare Conference in New York City, on February 13, 2013, at 1:30 p.m. ET.
During the mid-day trading hours, Dendreon Corporation (NASDAQ:DNDN) surged +5.85% to $6.52 with the total traded volume of 5.19 million shares.
Celsion Corporation (NASDAQ:CLSN) yesterday declared that Zheijang HISUN Pharmaceutical Company (HISUN) does not plan to follow the exclusive choice to authorizeThermoDox® for the Greater China market. Therefore, the parties will not enter into the exclusive license contract, and Celsion will not get nor will it need any future payment for the option or license, as anticipated in the Exclusive Option Agreement.
In the mid-day, Celsion Corporation (NASDAQ:CLSN) moved up +0.82% to $1.23 with the total traded volume of 3.44 million shares. CLSN has market cap of 43.42 million.
Gilead Sciences, Inc. (NASDAQ:GILD) declined -1.06% to $40.10 in the mid-day trading hours, with the total traded volume of 4.53 million shares. Its fifty two week range was $21.91-$41.34. The total market capitalization remained $60.82 billion.
GILD is ahead its 52 week low with 82.60% and its last month price volatility remained 2.57%. Its beta coefficient was 0.47 with a target price of $42.67. In its share capital GILD has 1.52 billion outstanding shares while 1.50 billion shares have been floated in market. GILD has insider ownership of 0.57% with its institutional ownership remained 94.63%. Company’s current year earnings per share grew with 6.82% while the five year EPS growth rate was +20.14%.
Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) declared today that the company is planned to present a corporate summary at two upcoming investor conferences, 15th Annual BIO CEO & Investor Conference on February 12, 2013, at 1:30 p.m. Eastern Time and Leerink Swann Global Healthcare Conference on February 13, 2013, at 2:30 p.m. Eastern Time, at The Waldorf Astoria in New York City.
In the mid-day, Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) moved up +2.32% to $8.83 with the total traded volume of 3.06 million shares.
Want to Learn How to Trade Penny Stocks? Click Here and Join Best Penny Stock Newsletter.
See More Updates on Our Blog: http://universalpennystocks.com/blog/index.php
About Universal Penny Stocks
universalpennystocks.com is an Independent Company, our focus is on small cap stocks that trade on OTCBB and OTC markets, and are mostly referred to as “penny stocks”. These are stocks that normally trade under $5 a share and could offer the greatest potential return on your short or long term investment. You must read our Disclaimer page for more information regarding conflicts of interest and the risks involved.
We try to spot stocks in all types of market conditions. In addition, we provide emerging small cap companies with profiling and investor relations services for compensation. If you believe your company is an emerging company, with a solid product, or a company that offers our members a profitable short or long term opportunity please feel free to send us an e-mail and we’ll review the company and reply to your inquiry promptly. Please provide as much information you believe we’ll need to review your request.
